Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation

被引:20
作者
Alonso, O
Loinaz, C
Moreno, E
Jiménez, C
Abradelo, M
Gómez, R
Meneu, JC
Lumbreras, C
García, I
机构
[1] Univ Complutense Madrid, Hosp 12 Octubre, Dept Surg & Abdominal Organ Transplantat, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Hosp 12 Octubre, Infect Dis Unit, E-28040 Madrid, Spain
关键词
donor age; fibrosing cholestatic hepatitis; hepatitis C; liver transplant; severe recurrence;
D O I
10.1111/j.1432-2277.2005.00114.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The association between donor age and the severity of recurrent hepatitis C and, whether there is any donor age above which severity of recurrence increases significantly, were analyzed. A total of 131 liver grafts of hepatitis C virus (HCV)-infected recipients were selected for the study. Distribution of donor age was compared between grafts with and without severe recurrence. The risk of developing severe recurrence as well as the hepatitis-free, severe hepatitis-free and HCV-related graft survival was compared between different donor age groups. Mean donor age was higher for grafts with severe recurrence (P = 0.007). The risk of developing severe recurrence within 2 years post-transplant increased with donors aged >= 50 years (RR = 1.34) and donors aged >= 70 years (RR = 1.61). Five-year severe hepatitis-free survival rates decreased progressively when donor age was over 50 years (P < 0.001). The study shows 50 and 70 years as the donor age cut-off points above which the evolution of HCV-infected recipients worsens.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 24 条
[1]   THE USE OF MARGINAL DONORS FOR ORGAN-TRANSPLANTATION - THE INFLUENCE OF DONOR AGE ON OUTCOME [J].
ALEXANDER, JW ;
VAUGHN, WK .
TRANSPLANTATION, 1991, 51 (01) :135-141
[2]   Hepatitis C and liver transplantation [J].
Berenguer, M ;
Wright, TL .
GUT, 1999, 45 (02) :159-163
[3]   Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].
Berenguer, M ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Martinez, F ;
Carrasco, D ;
Moya, A ;
Orbis, F ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2002, 36 (01) :202-210
[4]   Host and donor risk factors before and after liver transplantation that impact HCV recurrence [J].
Berenguer, M .
LIVER TRANSPLANTATION, 2003, 9 (11) :S44-S47
[5]   Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C [J].
Burak, KW ;
Kremers, WK ;
Batts, KP ;
Wiesner, RH ;
Rosen, CB ;
Razonable, RR ;
Paya, CV ;
Charlton, MR .
LIVER TRANSPLANTATION, 2002, 8 (04) :362-369
[6]   The impact of donor age on liver transplantation:: Influence of donor age on early liver function and on subsequent patient and graft survival [J].
Busquets, J ;
Xiol, X ;
Figueras, J ;
Jaurrieta, E ;
Torras, J ;
Ramos, E ;
Rafecas, A ;
Fabregat, J ;
Lama, C ;
Ibañez, L ;
Llado, L ;
Ramon, JM .
TRANSPLANTATION, 2001, 71 (12) :1765-1771
[7]  
BUSTILLO ED, 1998, J AM SOC NEPHROL, V9, P1109
[8]   Marginal donors in liver transplantation: The role of donor age [J].
De Carlis, L ;
Colella, G ;
Sansalone, CV ;
Aseni, P ;
Rondinara, GF ;
Slim, AO ;
Di Benedetto, F ;
Giacomoni, A ;
Fesce, R ;
Forti, D .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :397-400
[9]   Safe use of hepatic allografts from donors older than 70 years [J].
Emre, S ;
Schwartz, ME ;
Altaca, G ;
Sethi, P ;
Fiel, MI ;
Guy, SR ;
Kelly, DM ;
Sebastian, A ;
Fisher, A ;
Eickmeyer, D ;
Sheiner, PA ;
Miller, CM .
TRANSPLANTATION, 1996, 62 (01) :62-65
[10]  
GRANDE L, 1999, TRANSPLANT P, V31, P397